GK and monthly revision

Novel antibiotic Zaynich brings relief to the drought in antibiotic innovation

The novel antibiotic Zaynich, developed in India, has become the first fully indigenously created new chemical entity to receive approval from the US FDA for treating complicated urinary tract infections. This milestone marks a significant advancement in India's pharmaceutical innovation and self-reliance in drug development, highlighting the country's capabilities in producing essential medications. Its approval is expected to enhance treatment options and contribute to combating antibiotic resistance, making it a crucial development in public health.